EyePoint Pharmaceuticals EYPT
$ 7.16
0.49%
Quarterly report 2024-Q3
added 11-07-2024
EyePoint Pharmaceuticals General and Administrative Expenses 2011-2024 | EYPT
Annual General and Administrative Expenses EyePoint Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
40.1 M | 34.8 M | 25.6 M | 20.7 M | 17.9 M | 11.5 M | 11.2 M | 9.01 M | 8.06 M | 7.47 M | 7.17 M | 6.87 M | 8.1 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
40.1 M | 6.87 M | 16 M |
Quarterly General and Administrative Expenses EyePoint Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13 M | 12.8 M | - | 10.6 M | 9.06 M | 9.24 M | - | 9.21 M | 8.56 M | 8.55 M | - | 6.06 M | 5.18 M | 5.12 M | - | 5.8 M | 4.79 M | 4.36 M | - | 4.36 M | 4.82 M | 4.61 M | - | 4.16 M | 4.22 M | 4.16 M | 2.47 M | 2.57 M | 5.04 M | 2.57 M | 2.9 M | 3.28 M | 2.9 M | 3.28 M | 2.04 M | 1.97 M | 2.04 M | 1.97 M | 1.87 M | 1.73 M | 1.87 M | 1.73 M | 1.71 M | 1.81 M | 1.71 M | 1.81 M | 1.66 M | 1.62 M | 1.66 M | 1.62 M | 1.45 M | 2.06 M | 1.45 M | 2.06 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
13 M | 1.45 M | 4.15 M |